Archive - June 2018
Pfizer’s Xeljanz picks up a third indication in the US
Tesaro’s ovarian cancer drug Zejula added to Cancer Drugs Fund
Why It s Time to Get Smarter about Content Management and Document Production
1 In 5 Deaths Among Young Adults In US Is Opioid-Related
EMA facing higher-than-expected staff losses after Brexit
ICER says price of Amgen/Novartis’ Aimovig is OK – if used last-line
Roche ends development of olesoxime after “many difficulties”
Pfizer’s Xeljanz picks up a third indication in IBD